Factor predicted symptomatic COVID-19 infection and COVID-19 pneumonia in Thungsong Hospital, Nakhon Si Thammarat Province

Authors

  • Piamsook Sarikprueck Division Internal Medicine, Thungsong Hospital, Nakhon Si Thammarat Province, Thailand

Keywords:

COVID-19 infection, pneumonia, risk factor

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19 infection which the first case was identified on 30 December 2019, in Wuhan, China. The possible symptoms for many infected people include asymptomatic, a mild respiratory illness, severe illness such as pneumonia, acute respiratory distress syndrome (ARDS) and death. In Thailand we found the first confirmed case on 13 January 2020. This study aimed to determine the factors associated symptomatic COVID-19 and pneumonia in Thungsong Hospital from January 2019 to October 2021. The identified factors were analyzed using the Chi-square test, and only statistically significant factors were further analyzed by using multiple logistic regression (95%CI, p<0.05). A total of eligible 1,446 patients were divided into 266 asymptomatic, 644 symptomatic without pneumonia, and 536 with COVID-19 pneumonia. Factors associated with symptomatic COVID-19 without pneumonia were patients in the age group between 18-65 years which had underlying disease, the blood level of absolute lymphocyte(ALC) count less than or equal to 1,600, and blood level of C-reactive protein (CRP) higher than or equal to 10 (p<0.05). Factors significantly associated with COVID-19 pneumonia were patients in the age over 66 years, the clinical presentation of fever, dyspnea, the blood level of absolute lymphocyte (ALC) count less than or equal to 1,600, and blood level of C-reactive protein (CRP) higher than or equal to 10 (p<0.05). In conclusion, patients with such as risk factors should be monitored in order to ensure immediate medical treatment.

Downloads

Download data is not yet available.

References

Mohan BS, Vinod N. COVID-19: an insight into SARSCoV-2 pandemic originated at Wuhan city in Hubei province of China. J Infect Dis Epidemiol 2020;6:146

Roberts DL, Rossman JS, Jaric I. Dating first cases of COVID-19. PLos Pathog 2021;17(6):e1009620.

Angham GH, Mohammed K, Nany H, Emad Y, Salam AM. A Review on COVID-19 origin, spread, symptoms, treatment and prevention. BRIAC 2020;10(6):7234- 42.

Elisabeth M. COVID-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ 2020;368:m1036.

ศศินา สิมพงษ์, ศิริกาญน์ อุปสิทธิ์ , ศิริพร นครลำ, สิรินารถ ต้นสวรรค์, สุจิตรา ส่งสุข, สุทธิดา โพธิ์ ไทร, และคณะ. ปัจจัย ที่มีความสัมพันธ์กับพฤติกรรมการป้องกันโรคไวรัสโคโรนา 2019 ของนักศึกษาพยาบาลศาสตร์ มหาวิทยาลัยราชธานี. วารสารวิจัยสาธารณสุขศาสตร์ มหาวิทยาลัยราชภัฏอุบลราชธานี 2564;10(2):148-56.

Kotipan K. SARS-CoV-2 infection rates in two phases of the COVID-19 outbreak and the correlation of the cycle threshold of the two genes used in the diagnosis and pneumonia in Charoenkrung Pracharak Hospital. J Med Tech Assoc Thailand 2021;49(3):7922-33.

Min CC, Yu KP, Bong-Ok K, Donghwi P. Risk factors for disease progression in COVID-19 patients. BMC Infect Dis 2020;20:445.

Min HC, Hyunmin A, Han SR, Byung JK, Joonyong J, Moonki J, et al. Clinical characteristics and disease progression in early stage COVID-19 patients in South Korea. J Clin Med 2020;9:1959.

Chao Y, Miao Z, Yang L, Tinglin G, Chongyang O, Liye Yang, et al. Characteristics of asymptomatic COVID-19 infection and progression a multicenter, retrospective study. Virulence 2020;11(1):1006–14.

Elizabeth SS, Juraschek P. Diabetes epidemiology in the COVID-19 pandemic. Diabetes Care 2020;43:1690-4.

Giuseppe P, Martina V, Veronica R, Emanuela O. Is diabetes mellitus a risk factor for corona virus disease 19 (COVID 19). Acta Diabetol 2020; 57:1275–85.

Tomonori H, Tsuyoshi A, Heita K, Yoshitaka T, Tomoki Y,Shoji H, et al. Factors significantly associated with COVID-19 severity in symptomatic patients: a retrospective single-center study. Infect Chemother 2021; 27:7682.

Zarir FU, Awatansh RT, Viral JN. Prognostic factors for adverse outcomes in COVID-19 infection. J Assoc Physicians India 2020;68:56-9.

Giovanni P, Monia M, Cristel R, Tomasi, TomrisO. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci 2020;57(6):389-99.

Zhenyu K, Shanshan L, Yang G, Haifeng Z, Zili Z, Chunxia T, et al .Obesity is a potential risk factor contributing to clinical manifestations of COVID-19. Int J Obese 2020;44:2479 -85.

Moises MN, Rodolfo RR, Ivonne A, Roy G, Daniel O, Pacheo R, et al. Risk factors associated with SARSCOV-2 pneumonia in the pediatric population.Bol Med Hosp Infant Mex 2021;78(4):251-8.

Pongpirul WA, Wiboonchtikul S,Charoenpong L,Panitantum N, Vachiraphan A, Uttayamakul s, et al. Clinical course and potential predicting factors of pneumonia of adult patients with coronavirus disease 2019 (COVID-19) a retrospective observational analysis of 193 confirmed cases in Thailand. PLos Negl Trop Dis 2020; 14(10):e008806.

H.selcuk O, Pinar AY,Ummugulsum G, Asiye UD, Zehra D,Mehmet Y, etal. The factor predicting pneumonia in COVID-19 patients preliminary result from a university hospital in Turkey. Turk J Med Sci 2020; 50:1810-6

Efren MZ, Ramon AS, Xochitl T, Miguel Monica RS, Oliver MC. Independent factors of COVID-19 pneumonia in vaccinated Mexican adults.Int J infect Dis 2020;118:244-6.

Published

2023-12-27

How to Cite

สฤกพฤกษ์ เ. (2023). Factor predicted symptomatic COVID-19 infection and COVID-19 pneumonia in Thungsong Hospital, Nakhon Si Thammarat Province. Journal of Health Science of Thailand, 32(6), 1056–1065. Retrieved from https://thaidj.org/index.php/JHS/article/view/14905

Issue

Section

Original Article (นิพนธ์ต้นฉบับ)